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Abstract
Background: The prevalence of Paediatric HIV infection is largely unknown in many countries in sub-Saharan
Africa. This study was aimed at determining the prevalence, clinical pattern of HIV infection and outcome among
new patients aged <15 years using age-specific diagnostic methods.
Methods: A prospective cross sectional study was carried out using the provider initiated HIV testing and
counselling (PITC) model. HIV rapid test in parallel was used for screening and confirmation was with HIV DNA PCR
in children <18 months and Western Blot in children ≥ 18 months.
Results: A total of 600 children were enrolled with ages ranging between one day and 179 months. Male: female
ratio was 1.2:1. HIV seroprevalence was 12.3% and after confirmatory tests, the prevalence was 10%. Fourteen
(37.8%) of the children aged less 18 months were exposed but not infected. Mother-to-child transmission
accounted for 93.3% of cases. Features predictive of HIV infection were diarrhoea, cough, weight loss, ear discharge
generalized lymphadenopathy, presence of skin lesions, parotid swelling and oral thrush. About 75% presented in
advanced or severe clinical stages of the disease, 56.8% had severe immunodeficiency while 50% had viral loads
more than 100,000 copies/ml. Mortality rate was 14.3% among HIV positive compared with 11.3% in HIV negative
children but was not significant. Among the HIV positive children, 26.7% were orphans.
Conclusions: The prevalence rate of HIV infection among new patients screened using the PITC model was high,
majority resulting from mother-to-child transmission. Most children presented in advanced stages of the disease
and mortality rate among them was high. Though, the study site being a referral centre might have contributed to
the high prevalence observed in this study, there is a need to expand access to PMTCT services, ensure
implementation of PITC in paediatric settings and expand support services for HIV infected children.
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Background
The Human Immunodeficiency Virus (HIV) pandemic is
one of the most devastating epidemics in recorded his-
tory. Though revised estimates in 2007[1] indicated sub-
stantial reduction in the estimated number of people
living with HIV, sub-Saharan Africa still accounts for
over two thirds (68%) of infections[1]. The global
prevalence of HIV has remained unchanged at 0.8%
between 2001 and 2007[1], though regional variations
exist. Sub-Saharan Africa has the highest prevalence of
5.0%[1], with prevalence rates a high as 39% in Kwa-
Zulu-Natal province of South Africa[2].
Nigeria currently has the largest burden of paediatric
HIV in the world, but few studies have been done on
HIV in children in Nigeria. Prevalence rates in Nigeria
are gotten from sentinel surveys using first time ANC
attendees, the latest being (4.6%)[3] in 2007. There is
however no figure for the paediatric age group[4].
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Nigerian children, showed seroprevalence rates ranging
from 5.7 - 20%[5]. Many employed serological assays
making their application rather limited[5-8].
More than 90% of new paediatric HIV cases are
acquired through mother-to-child-transmission[9].
Transfusion associated HIV infection is less common
and often in settings without routine HIV screening of
blood products, especially in developing countries
[5,6,8].
The clinical presentation varies with the degree of
immunosuppression, from asymptomatic infection to
Acquired Immunodeficiency Syndrome (AIDS) charac-
terized by severe immunosuppression and recurrent
severe opportunistic infections. The predominant mor-
bidity pattern in HIV infected children include respira-
tory infections, otitis media, malnutrition, diarrhoea
disease, anaemia and septicaemia[5-8,10-14]. These con-
ditions are also prevalent among children without HIV
infection in most developing countries leading to a low
index of suspicion for HIV infection and hence late
diagnosis. The provider initiated HIV testing and coun-
selling (PITC) has been proposed as one of the ways to
increase the uptake of HIV testing and thus improve
access to HIV prevention, treatment and care services,
especially in areas with generalized epidemics[15]. The
objectives of this study were to determine the preva-
lence and clinical pattern of HIV infection among chil-
dren seen in the Department of Paediatrics of the
University College Hospital (UCH), Ibadan using the
PITC model and age-appropriate serological and virolo-
gical methods.
Methods
The study was a prospective cross-sectional study
among new patients aged less than 15 years presenting
at the Department of Paediatrics of UCH, Ibadan from
July to December 2007. UCH Ibadan is the premier
teaching hospital in Nigeria and a referral hospital for
South-West Nigeria and beyond. All consecutive new
patients aged less than 15 years whose parents/guardians
gave written informed consent (and assent obtained for
those aged 10-14 years) were enrolled into the study
using the WHO guideline on PITC till the calculated
sample size was exceeded. Detailed clinical information
was collected using case record forms. These included
demographic and socioeconomic data[16], source and
reason for referral, immunization history, nutritional
history, history of risk factors for HIV infection, present-
ing complaints, details of symptoms, any co-morbid
state and a thorough physical examination.
All subjects had an initial double rapid HIV antibody
tests in parallel at the point-of-care using HIV 1/2
STAT-PAK™ (by CHEMBIO DIAGNOSTICS
SYSTEMS, INC. Medford, New York 11763 USA) and
Determine™ HIV 1/2 (by ABBOTT JAPAN CO.,LTD.
Minto-Ku, Tokyo, Japan) according to the manufactures’
instructions. HIV infection was confirmed in those with
a reactive rapid test by Western Blot test if aged ≥18
months and HIV DNA PCR tests for those <18 months,
these were done at the Department of Virology, UCH
Ibadan, a referral centre for HIV testing. Children with
double rapid HIV antibody tests that were non-reactive
were reported as HIV-uninfected[17,18]. Patients with
HIV infection had viral load estimation, CD4 count and
percentages and were enrolled at an on-going HIV/
AIDS treatment programme at the study centre. Those
requiring admission were admitted into the wards at the
study site by the managing teams and were followed up
by the study team till discharge or otherwise and the
final diagnosis at discharge recorded.
Ethical approval for the study was obtained from the
Joint University of Ibadan/University College Hospital
Ibadan Health Research and Ethics Committee.
Results
Six hundred patients were enrolled into the study, of
which 329 (54.8%) were males and 271 (45.2%) were
females, giving a male: female ratio of 1.2:1. The age of
the subjects ranged from one day to 179 months with a
median age of 16 months, 248(41.3%) were less than 12
months and 106 (17.7% ) were neonates (Table 1).
S e v e n t yf o u ro ft h e6 0 0c h i l d r e nt e s t e dw e r er e a c t i v et o
the two rapid HIV test kits used, giving HIV seropreva-
lence rate of 12.3%. Of the 74 seropositive children, 60
were confirmed to be HIV infected, this was by HIV
DNA PCR in 23 (38.3%) children aged <18 months and
by Western Blot in the remaining 37 (61.7%) children
Table 1 Demographic characteristics of the subjects
Age Gender Total
Male Female
No. % No. % No. %
<12 months 134 40.7 114 42.1 248 41.3
12 - <24 months 46 7.7 42 7.0 88 14.7
24 - <36 months 21 3.5 19 3.2 40 6.7
36 - <48 months 25 4.2 19 3.2 44 7.3
48 - <60 months 22 3.7 16 2.7 38 6.3
60 - <180 months 81 24.6 61 22.5 142 23.7
Social class
I 22 6.7 19 7.0 41 6.8
II 58 17.6 41 15.1 99 16.5
III 109 33.4 85 31.4 194 32.3
IV 121 37.1 104 38.4 225 37.5
V 10 3.0 17 6.3 27 4.5
Unknown 9 1.8 5 1.8 14 2.3
Total 329 54.8 271 45.2 600 100
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in the study population. Fourteen (37.8%) of the chil-
dren aged <18 months were retroviral exposed but not
infected as at the time of screening. In 548 children,
HIV was not suspected based on their clinical features,
nor were they referred specifically for HIV testing based
on a prior positive testing else where or parental seropo-
sitivity. Of these, 3.1% (17/548) were seropositive and
1.8% (10/548) were later confirmed to be HIV infected
using age-specific confirmatory methods.
The probable mode of transmission was mother-to-
child transmission in 56 (93.3%) children, via blood
transfusion in 2(3.33%), while the mode of transmission
was inconclusive in 2 (3.33%). The inconclusive modes
of transmission were in two se x u a l l ya c t i v ea d o l e s c e n t s
who had never received blood transfusion. The first was
a 13 year old girl whose mother was HIV positive and
the second was a 14 year old boy from an orphanage
whose mother was a deceased commercial sex worker.
His elder brother who resides in the same home was
seronegative.
Fever was the commonest presenting symptoms in
HIV infected children, other presenting symptoms were
cough, diarrhoea, weight loss/poor weight gain, and ear
discharge. (Table 2). All these features were significantly
more common in HIV infected patients compared with
the HIV uninfected group. Also a significant proportion
(p = 0.000) of HIV infected children had oral thrush,
generalized lymphadenopathy, parotid fullness, otor-
rhoea, skin lesions, hepatomegaly and splenomegaly.
Less common features among the HIV infected children
were seizures, loss of consciousness and jaundice. A sig-
nificant proportion of the HIV infected children were
orphans (16/60) 26.7%, compared with HIV uninfected
children (23/517) 4.4%.
Symptoms predictive of HIV infection by logistic
regression analysis after controlling for confounding
symptoms were diarrhoea, cough, weight loss and ear
discharge, with diarrhoea being the most independent
predictor of HIV infection (Table 3). Signs predictive of
HIV infection were generalized lymphadenopathy, pre-
sence of skin lesion, parotid swelling and oral thrush
being predictive of the presence of HIV infection after
controlling for other confounding signs (Table 3).
The Z-scores of Weight-for-length/height (WHZ),
Length/height-for-age (HAZ) and Weight-for-age
(WAZ) were significantly different for the HIV infected
and HIV uninfected groups. The proportion on children
who had Weight-for-length/height (WHZ) Z scores
indicative of mild-to-moderate and severe malnutrition
Table 2 Symptoms, signs and orphan status in HIV positive and negative subjects
HIV Status
Infected
(n = 60)
Uninfected
(n = 540)
Total
N = 600
OR (95% CI) P
No. % No. % No. %
Symptom
Fever 45 75.0 310 57.4 355 59.2 2.23(1.21,4.10) 0.008
Cough 39 65.0 128 23.7 167 27.8 5.98(3.39,10.53) 0.000
Fast breathing 8 1.3 82 15.2 90 15.0 0.86(0.39,1.88) 0.849
Diarrhoea 24 40.0 57 10.6 81 13.5 5.65(3.15,10.14) 0.000
Weight loss/falter 25 41.7 63 11.7 88 14.7 5.41(3.04,9.62) 0.000
Seizures 2 3.3 106 19.6 108 18.0 0.14(0.03,0.59) 0.001
Coma - - 21 3.9 21 3.5 - 0.254
Chronic diarrhoea 7 11.7 1 1.9 8 1.3 71.19(8.60,589.65) 0.000
Recurrent otorrohea 11 18.3 11 2.0 22 3.7 10.80(4.45,26.17) 0.000
Signs
Pallor 20 33.3 150 27.8 170 28.3 1.30 (0.74,2.30) 0.368
Jaundice 2 3.3 74 13.7 76 12.7 0.22 (0.05,0.91) 0.022
Oral thrush 8 13.3 8 1.5 16 2.7 10.23 (3.69,28.4) 0.000
Lymphadenopathy 33 55.0 33 6.1 66 11.0 18.78 (10.12,34.86) 0.000
Parotid fullness 13 21.7 3 0.6 16 2.7 49.51(13.63,179.92) 0.000
Otorrhoea 7 11.7 6 1.1 13 2.2 11.76 (3.81,36.26) 0.000
Skin lesions 24 40.0 32 5.9 56 9.3 10.58 (5.65,19.83) 0.000
Hepatomegaly 43 71.7 236 43.7 279 46.5 3.26 (1.81,5.86) 0.000
Splenomegaly 19 31.7 66 12.2 85 14.2 3.33 (1.82,6.08) 0.000
Persistent fever: Unexplained fever (intermittent or constant) lasting ≥ 1 month, Chronic diarrhoea: At least two loose stools per day for ≥ 30 days, Recurrent
otorrhoea: ≥ 2 episodes of ear discharge from the same ear
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dren, while the proportion in children who had Length/
height-for-age (HAZ) and Weight-for-age (WAZ) Z
scores indicative of mild-to-moderate and severe malnu-
trition were significantly higher in the HIV infected chil-
dren than in the HIV uninfected children. In all the
parameters assessed, the proportion of the various
degrees of wasting and stunting was higher among the
HIV infected patients (Tables 4 and 5). None of the
children in the study population had oedema.
Associated diagnoses in the HIV infected patients
were Bronchopneumonia (7/60, 11.7%), Pneumocystis
jiroveci pneumonia (3/60, 5.0%), Chronic otitis media
(12/60, 20.0%), Pulmonary tuberculosis (24/60, 40.0%),
Tuberculous adenitis (1/60,1.7%), Acute diarrhoea dis-
ease (16/60, 26.7%), Chronic diarrhoeal disease (8/60,
13.3%), Failure to thrive (2/60, 3.3%), PEM Marasmus
(44/60, 73.3%), Acute uncomplicated malaria (5/60,
8.3%), Septicaemia (7/60, 11.6%), Pyomyositis (1/60,
1.7%), Pharyngitis (1/60, 1.7%), asymptomatic (4/60,
6.7%). These were not mutually exclusive with multiple
diagnoses in 58.3% of patients.
The revised WHO Paediatric Clinical Staging of HIV/
AIDS was used to classify degree of immunosuppresion
[19]. Most patients presented in clinical stages 3 (40.0%)
and 4 (33.0%), with advanced immunodeficiency in
13.6% and severe immunodeficiency in 56.8%. The viral
load of the patients ranged from 200 to 4907941 viral
copies/μlitre of blood with a median of 132396 viral
copies/μlitre of blood. Most of the children had viral
load of more than 100 000 viral copies/μlitre of blood,
with 35.7% having viral load of 100 000 - <1 000 000
copies/μlitre of blood and 23.8% with viral load of >1
000 000 viral copies/μlitre of blood (Table 6). The
admission and mortality pattern among the subjects
were; for HIV infected children, 70% (42/60) and 14.3%
compared with HIV uninfected children of 81.7%(441/
540) admitted and 11.4% mortality.
Discussion
The prevalence rate of paediatric HIV infection of 10.0%
in this study is lower than earlier reports from Africa
[20,21] and Nigeria[5,6,22]. However, the studies from
Nigeria were among high risk groups suspected to have
immunosuppression and all studies were done before
HIV DNA PCR testing facilities were available and used
serological tests which might give a false positive results
in patients aged <18 months. Other studies that
reported lower prevalence rates [6,8,7] were mostly ret-
rospective and among hospitalized children thus some
cases might have been missed. Conversely, the study site
being a referral site might have accounted for the high
prevalence rate observed. One limitation of the study
however, is in the subset of HIV exposed infants <6
weeks old and those still breast feeding. This group will
need a repeat HIV DNA PCR at 3 months and 6 weeks
after stopping breastfeeding due to the less than optimal
sensitivity of the HIV DNA PCR in infants <6 weeks
and continued exposure from breastfeeding, some of
these patients might actually turn out to be HIV
infected. This however was not captured in this study
being cross-sectional in design. A longitudinal study
would better describe this.
The Provider Initiated HIV Testing and Counselling
guideline[1,15] is useful in identifying HIV infection in
patient presenting to health facilities and do not have
the classical symptoms and signs of the infection,
thereby limiting missed opportunities for early detection
and care. In this study, of such children without the
classical features of HIV Infection, 17 (3.1%) children
were found to be seropositive for HIV infection, and 10
(1.8%) were confirmed positive for retroviral infection.
This finding gives credence to the need to offer routine
screening to all children presenting in health facilities as
provided in the WHO guideline[1,15]. In addition HIV
Table 3 Logistic regression analysis of symptoms and
signs predictive of HIV infection
P Odds ratio
(OR)
95.0% CI forOR
Diarrhoea .000 0.281 0.143, 0.554
Cough .000 0.224 0.123,0.408
Weight loss/FTT .002 0.350 0.180,0.679
Ear discharge .013 0.200 0.056,0.716
Generalized
lymphadenopathy
0.000 0.141 0.067,0.297
Skin lesion 0.000 0.210 0.095,0.463
Parotid fullness 0.010 0.121 0.024,0.604
Oral thrush 0.026 0.223 0.060,0.834
Hepatomegaly 0.061 0.499 0.242,1.033
Splenomegaly 0.284 0.629 0.271,1.459
Otorrhoea 0.753 0.750 0.126,4.484
Table 4 Mean Z-scores of nutritional indices among HIV positive and negative subjects
Nutritional status (Z-score) HIV positive (n = 60) HIV negative (n = 540) Z-test P
Mean SD Mean SD
Weight-for-length/height (WHZ) -1.63 2.06 -0.93 2.47 2.37 0.017
Length/height-for-age (HAZ) -3.23 2.19 -1.86 3.55 7.60 0.000
Weight-for-age (WAZ) -3.03 1.75 -1.79 2.13 6.26 0.000
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also seen in HIV uninfected children in the general
population as highlighted in this study.
The controversy as to whether gender is a risk factor
for MTCT of HIV [23,24] continues. In this study, as
observed by Adejuyigbe et al[5] and Oniyangi et al[8],
there was a slight female preponderance, which contrast
with other reports from Africa[11,14,22,20]. MTCT
accounting for 93.3% of infection in this study indicates
the need to intensify efforts to get MTCT service to the
large numbers of Nigerian women needing it. Transmis-
sion via blood transfusion and possible sexual route
observed in this study means that as in other parts of
Nigeria[5,6,8,11,22] calls for the need to improve blood
transfusion services and need for paediatricians to
always consider sexual mode of transmission when
attending to HIV infected adolescents.
The clinical presentation of children with HIV infec-
tion in Ibadan is similar to that from other parts of
Africa and Nigeria[8,11,22,25]. These symptoms and
signs are also seen in HIV negative children but the
Odds Ratio show the higher likelihood of HIV infected
children presenting with these features and some were
predictive of HIV infection on multivariate regression
analysis. Their presence, singly or in combination,
should heighten the index of suspicion for HIV infection
in children. The rarity of neurological features in HIV
infected children observed here has been reported ear-
lier[22] and might be due to the relatively long time
required for neurological features to develop.
Malnutrition, particularly marasmus, and pneumonia are
prevalent clinical syndromes in HIV infected African chil-
dren[5,22,20]. Malnutrition was present in 76% of children
in this study. It has been recognized as an underlying con-
tributing factor to childhood morbidity and mortality and
contributes to about 56% of under-five mortalities in the
developing countries. The severe malnutrition observed in
HIV infected children is definitely a major factor that
needs attention. The high TB-HIV co-infection rate in this
study re-echo’s the unholy alliance between these two con-
ditions and the burden they pose on the health of children
in our environment. Efforts to expand HIV prevention,
treatment and care services must thus be matched by
similar services for TB prevention and treatment.
Based on the revised WHO Paediatric Clinical Staging
of HIV/AIDS[19], about 75% of the patients in this study
presented in advanced clinical stages 3 and 4, and similar
observations had been reported from other parts of
Nigeria [11]. Also 57.8% were severely immunosup-
pressed which also compares with 55.7% with severe
immunosuppression observed by Ugochukwu et al.[11]
In addition, 50% had viral loads >100,000 copies/ml. The
implication of these is that most children presented at
the advanced stages of the disease associated with poor
prognosis and need for antiretroviral therapy. There is
thus a need to evolve methods of early identification and
proper management of HIV infected children to prevent
clinical and immunological deterioration, which further
reiterates the need for implementing the PITC guidelines.
HIV contributes significantly to orphan rate, with
rates as high as 25.75% and 10.8% in sub-Saharan Africa
and Nigeria respectively[1,3]. A similarly high orphan
rate among HIV positive children in this study calls for
an urgent need for support services for both HIV
affected and infected children bearing in mind the poor
social services in these parts of the world. In addition
efforts need to be intensified to reduce HIV infection
and AIDS related deaths in adults by scaling up HIV
prevention interventions and improved access to antire-
troviral therapy as this will reduce paediatric HIV from
MTCT and the number of AIDS orphans.
Table 6 Clinical Staging, immunological category and
viral load pattern of HIV positive children
Clinical stage No(%)
Stage1 -Asymptomatic 4(6.7)
Stage 2 - Mild 12(20.0)
Stage 3 - Advanced 24(40.0)
Stage 4 - Severe 20(33.0)
Total 60(100.0)
Immunologic category
No significant Immunodeficiency 10(22.7)
Mild Immunodeficiency 3(6.8)
Advanced Immunodeficiency 6(13.6)
Severe Immunodeficiency 25(56.8)
Total 44*(100.0)
Viral Load (copies/μlitre of blood)
<1000 4(9.5)
1000 - <100 000 13(31.0)
100 000 - <1 000 000 15(35.7)
>1 000 000 10(23.8)
Total 42*(100.0)
* The viral load and CD4count/% of some patients were not processed at
admission due to logistic problems at the laboratory.
Table 5 Prevalence of mild-moderate and severe
malnutrition in HIV positive and negative patients
Nutritional
status
All subjects
(n = 600)
HIV positive
(n = 60)
HIV
negative
(n = 540)
Z-
test
P
%
Prevalence
%
Prevalence
%
Prevalence
WHZ <-2.0 30.2 34.2 29.8 0.45 0.164
HAZ <-2.0 46.6 71.8 44.1 5.25 0.003
WAZ <-2.0 44.5 76.3 42.5 5.07 0.030
WHZ <-3.0 18.0 26.3 17.1 2.10 0.180
HAZ <-3.0 31.6 53.8 29.3 6.13 0.003
WAZ <-3.0 27.5 46.3 25.6 4.96 0.009
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the study population, with a slightly higher rate of 14.3%
among HIV positive children. Higher mortality figures of
26.1-46.3% have been reported from other parts of
Nigeria[5,6,8], while in a prospective 5 year study of HIV
infected Rwandan children[12], the estimated risk of
death at 2 and 5 years of age was 45% and 62%, respec-
tively and the risk of dying was 21 times higher than in
uninfected children. The high mortality figures observed
in these studies were in the pre-antiretroviral era and so
t h el o w e rm o r t a l i t yr a t eo b s erved in this study could
have been due to the antiretroviral treatment programme
in place at the study centre which facilitated the manage-
ment of these patients and thus gave a better outcome.
Conclusions
The prevalence rate of HIV infection among new patients
screened using the PITC model in this study was high and
majority were as a result of mother to child transmission.
Some children without clinical features suggestive of
immune suppression were found to be positive using the
PITC model adopted in the study. Most children pre-
sented in advanced stages of the disease and mortality rate
among them was high. HIV infected children need to be
identified early to reduce morbidity and mortality and
there is the need to expand access to PMTCT services,
ensure implementation of PITC in paediatric settings and
expand support services for HIV infected children.
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